Treatment options for localized prostate cancer

Area of Science:

• Urology
• Oncology
• Medical Guidelines

Background:

• Prostate cancer detection in the US heavily relies on prostate-specific antigen (PSA) testing, identifying localized disease in most cases.
• Current standard treatment for localized prostate cancer involves surgery or radiotherapy.
• A significant portion of detected prostate cancers are low-risk, potentially suitable for less invasive management.

Purpose of the Study:

• To outline the concept and application of active surveillance for managing low-risk prostate cancer.
• To provide guidance on selecting appropriate treatment strategies based on patient and cancer characteristics.
• To compare the efficacy and side effect profiles of different prostate cancer treatment modalities.

Main Methods:

• Review of clinical guidelines for prostate cancer management.
• Analysis of treatment options including active surveillance, radical prostatectomy, external beam radiation therapy, and brachytherapy.
• Consideration of patient-specific factors such as cancer stage, grade, PSA levels, and life expectancy.

Main Results:

• Active surveillance involves close monitoring of low-risk prostate cancer, with intervention only upon disease progression.
• Clinical guidelines assist in differentiating between candidates for active surveillance versus definitive treatment.
• Radical prostatectomy and external beam radiation therapy are comparable in effectiveness for higher-risk cancers but differ in adverse events.
• Brachytherapy is a viable option for low- and moderate-risk patients.

Conclusions:

• Active surveillance represents a paradigm shift for managing select low-risk prostate cancer patients, avoiding immediate treatment burdens.
• Personalized treatment decisions should integrate cancer-specific factors and patient comorbidities for optimal outcomes.
• Further evidence is needed to establish the superiority of minimally invasive surgical techniques (robotic, laparoscopic) and cryotherapy over open radical prostatectomy.